The Ministry of Health<\/strong> in the Dominican Republic<\/strong> recently announced the acquisition of two GeneXpert devices<\/strong> to enhance molecular detection of tuberculosis (TB)<\/strong> within public healthcare systems. This investment\u2014a total of RD 3,377,100.00<\/strong>\u2014marks a significant step in the national effort to increase rapid and accurate TB diagnostics across the country.<\/p>\n The introduction of these new machines boosts the total GeneXpert devices in the public network to 36<\/strong>, significantly improving diagnostic capabilities<\/strong>. These advanced devices facilitate quick testing, which is crucial for timely treatment, potentially saving lives and mitigating the spread of the disease.<\/p>\n In 2025, the National Tuberculosis Control Program (PNCT)<\/strong> reported 4,447 new TB cases<\/strong>. Notably, 855<\/strong> of these cases were linked to individuals with TB\/HIV co-infections. Moreover, the recorded mortality rate stood at 0.6 per 100,000 inhabitants<\/strong>, highlighting the ongoing public health challenge TB poses in the region.<\/p>\n Julio Landr\u00f3n<\/strong>, the director of the National Health Service (SNS)<\/strong>, emphasized that these new GeneXpert devices represent much more than equipment; they are an investment in lives<\/strong>. \u201cEach timely diagnosis increases the chances of recovery, reduces complications, and decreases transmission risk,\u201d he stated, underscoring the technology’s crucial role in fighting TB.<\/p>\n Data from the SNS<\/strong> reveals a significant uptick in TB testing, with 31,047 molecular tests<\/strong> conducted in 2025. As of early 2026, 2,254 new cases<\/strong> have been identified, with all patients currently undergoing treatment. The public health initiative aims to exceed 92% coverage<\/strong> of its TB program through 1,523 health facilities<\/strong> throughout the nation.<\/p>\n Minister Atallah<\/strong> confirmed that the new equipment aligns with the government’s objective of guaranteeing universal access<\/strong> to essential diagnostic and treatment services. \u201cOur vision is to create a future free from the threat of TB,\u201d he asserted, emphasizing that each new machine paves the way for earlier detection and timely intervention.<\/p>\n Eladio Perez<\/strong>, the vice minister of Collective Health<\/strong>, further remarked on the necessity of extending molecular diagnosis coverage, which is vital for meeting national goals in eliminating TB. He reiterated that despite being a preventable and treatable illness, TB remains a critical global health issue due to the rise in drug-resistant<\/strong> strains.<\/p>\n The introduction of two new GeneXpert devices represents a noteworthy advancement in the Dominican Republic\u2019s public health landscape. By strengthening diagnostic capabilities, these additions facilitate the timely treatment of tuberculosis, thereby contributing positively to the nation\u2019s health objectives. Ensuring early detection and effective monitoring will empower the country’s efforts in combating this persistent public health challenge.<\/p>\nImportance of GeneXpert Technology<\/h3>\n
Recent Tuberculosis Statistics<\/h4>\n
A Step Forward in Healthcare<\/h3>\n
Expansion of Diagnostic Coverage<\/h3>\n
Ministerial Perspectives<\/h4>\n
Conclusion: A New Era for Tuberculosis Control<\/h3>\n